Industry leaders, patient advocates, regulators, policymakers collaborate to identify strategies for better data use in healthcare innovation CAMBRIDGE, MASSACHUSETTS—The MIT NEW Drug Development ParadIGmS (NEWDIGS) initiative, an international biomedical innovation … Read More
AI and machine learning key enablers of healthcare value, expert panel says
MIT NEWDIGS Director and advisor speak at LIGHT Forum on AI in Healthcare CAMBRIDGE, MASSACHUSETTS—MIT NEW Drug Development ParadIGmS (NEWDIGS) director Dr Gigi Hirsch, and program advisor R. John Glasspool … Read More
MIT NEWDIGS Hosts Design Lab on New Gene and Oncology Therapy Financing Models
Industry leaders, patient advocates, policymakers collaborate to lower barriers to potentially curative treatments CAMBRIDGE, MASSACHUSETTS—The MIT NEW Drug Development ParadIGmS (NEWDIGS) initiative, an international biomedical innovation “think and do tank” … Read More
Dr Gigi Hirsch and John Glasspool to speak at LIGHT Forum
MIT NEWDIGS director Dr Gigi Hirsch and her colleague R. John Glasspool will address the LIGHT Forum on the impact of artificial intelligence and Big Data on healthcare. They will … Read More
Hilary Malone joins MIT NEWDIGS Executive Committee
Regulatory and business leader will help accelerate system-wide biomedical innovation CAMBRIDGE, MASSACHUSETTS, 1 MARCH 2017—The MIT New Drug Development Paradigms Initiative (NEWDIGS) announced today that Hilary Malone, Chief Regulatory Officer … Read More
MIT NEWDIGS Hosts Design Lab on Clinical Trial Innovation
Biomedical Innovation Initiative Supporting New NIH-Funded Trial Innovation Center CAMBRIDGE, MASSACHUSETTS—The MIT NEW Drug Development ParadIGmS (NEWDIGS) initiative, an international biomedical innovation “think and do tank”, co-hosted an “Efficacy to … Read More
Kay Larholt joins MIT NEWDIGS as Director of Integrated Knowledge Solutions
Industry veteran will lead development of new decision support technologies CAMBRIDGE, MASSACHUSETTS—The MIT New Drug Development Paradigms Initiative (NEWDIGS) announced today the hire of Dr. Kay M. Larholt as their … Read More
OpEd: Mark Trusheim & Peter B. Bach on How the US Can Beat Hepatitis C
How the US Can Beat Hepatitis C: Don’t buy the pills, buy the company Pharma veteran and physician advance provocative solution to overcome treatment costs CAMBRIDGE, MASSACHUSETTS—In an article published … Read More
Special Issue of Clinical Pharmacology & Therapeutics spotlights Adaptive Biomedical Innovation
Expert views on strategies for getting new science to patients faster, safely, and affordably CAMBRIDGE, Mass., Nov. 9, 2016—Clinical Pharmacology & Therapeutics (CPT), a cross-disciplinary journal in experimental and clinical … Read More
NEWDIGS convenes healthcare leaders to pioneer new pharmaceutical financing strategies
CAMBRIDGE, Mass., Oct. 27, 2016 — Patient advocates, healthcare payers, industry, and academic stakeholders gathered today at the Massachusetts Institute of Technology (MIT) to map out a new strategy for … Read More